Arkadios Wealth Advisors Neurocrine Biosciences Inc Transaction History

Arkadios Wealth Advisors

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 03, 2022	SELL	$79.65 - $106.22 $12,425 - $16,570	-156 Closed	0 $0
Q3 2021 Oct 19, 2021	SELL	$86.18 - $99.03 $5,084 - $5,842	-59 Reduced 27.44%	156 $14,000
Q2 2021 Jul 28, 2021	SELL	$89.43 - $102.27 $1,967 - $2,249	-22 Reduced 9.28%	215 $20,000
Q1 2021 Apr 26, 2021	BUY	$87.57 - $119.4 $11,208 - $15,283	128 Added 117.43%	237 $23,000
Q4 2020 Feb 09, 2021	BUY	$86.91 - $108.33 $9,473 - $11,807	109 New	109 $10,000

626

94M

632K

621K

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $13B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

Get notified when there are updates to the investment portfolio of Arkadios Wealth Advisors, based on Form 13F filings with the SEC.

Stay updated on Arkadios Wealth Advisors with notifications on news.